23 Amendments of Ulrike MÜLLER related to 2017/2254(INI)
Amendment 14 #
Draft opinion
Paragraph 2
Paragraph 2
2. Calls on the Commission and the Member States to take an ambitious approach to ensuring that the targets set out in their respective Action Plans are fully and effectively achieved, and to strictly monitor the results that have been achieved; Stresses that Member States' Action Plans must address animal husbandry comprehensively to fulfil the targets of the One Health approach;
Amendment 17 #
Motion for a resolution
Recital A
Recital A
A. whereas the excessive and inappropriatecorrect use of antibiotics and poor infection control practices in both human and veterinary medicine have progressively rendered antimicrobial resistance (AMR) a massive threat to humankind;
Amendment 27 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on the Commission and Member States to distinguish between livestock and pets, particularly in the design of monitoring and assessment of the use of antimicrobials and in the design of measures to address their use;
Amendment 34 #
Draft opinion
Paragraph 3
Paragraph 3
3. Calls for legislative solutions that will assist farmers in reducing the use of antibiotics in livestock farming, with the aim of prudent and responsible use of antimicrobials; insists that such legislative solutions must carefully address prophylactic and metaphylactic use, considering that it sometimes may be required to address a subliminal infection in a herd before a full outbreak occurs;
Amendment 35 #
Motion for a resolution
Recital B
Recital B
B. whereas the misincorrect use of antibiotics is eroding their efficacy and leading to the spread of highly resistant bacteria that are especially resistant to last- line antibiotics; whereas according to data provided by the OECD, an estimated 700 000 deaths worldwide may be caused by AMR every year;
Amendment 37 #
Draft opinion
Paragraph 3
Paragraph 3
3. Calls for legislative solutions that will assist farmers in reducing the use of antibiotics in livestock farming, with the aim of prudent and responsible use of antimicrobials; insists that such legislative solutions must address prophylactic and metaphylactic use; endeavours to keep the additional administrative burden as small as possible;
Amendment 58 #
Draft opinion
Paragraph 4
Paragraph 4
4. Calls for further research and development into new antimicrobials and encourages alternatives, such as vaccines, to be investigated, including the development of more sustainable farming systems based on less intensive farming modelsand animal friendly farming models to ensure adequate animal husbandry;
Amendment 68 #
Motion for a resolution
Recital E b (new)
Recital E b (new)
Eb. whereas action to reduce veterinary antimicrobial use has been uneven across EU countries as the latest data from the European Medicine Agency shows1a; whereas some Member States have achieved significant reductions in the use of veterinary antimicrobials over a short period of time thanks to ambitious national policies, as illustrated by a series of fact-finding missions carried out by the European Commission Health and Food Audits and Analysis Directorate1aa; _________________ 1a http://www.ema.europa.eu/ema/index.jsp? curl=pages/news_and_events/news/2017/1 0/news_detail_002827.jsp∣ =WC0b01ac05 8004d5c1antimicrobials 1aa http://ec.europa.eu/food/audits- analysis/audit_reports/index.cfm
Amendment 75 #
Motion for a resolution
Recital E c (new)
Recital E c (new)
Amendment 87 #
Draft opinion
Paragraph 6
Paragraph 6
6. Calls on the Commission and the Member States to ensure adequate funding for6. Believes that on-farm investments, such as in quality housing, ventilation, cleaning, disinfection, vaccination and bio-security, probiotics, prebiotics, gen- selection and bio-security must be encouraged and should not be undermined in the future CAP;
Amendment 98 #
Draft opinion
Paragraph 7
Paragraph 7
7. Emphasises the crucial role of education and training programmes, based on the latest scientific developments, in raising awareness about antimicrobial resistance and the prudent use of antimicrobials in veterinary medicine for farmers and those involved in livestock farming;
Amendment 102 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Stresses that the appropriatecorrect and prudent use of antimicrobials is essential to limiting the emergence of AMR in human healthcare, animal husbandry and aquaculture; stresses that there are considerable differences in the way Member States handle and address AMR; calls on the Commission to consider mandatory routine collection and submission of monitoring data at EU level and to establish indictors to measure progress in the fight against AMR;
Amendment 117 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on the Commission and Member States to distinguish between livestock and pets particularly in the design of monitoring and assessment of the use of antimicrobials in veterinary medicine, as well as in the design of measures to address their use;
Amendment 118 #
Draft opinion
Paragraph 8
Paragraph 8
8. Underlines the need to change the business culture employed by veterinary medicine producers, which encourages the use and overuse of certain medicines in order to generate profitslosely cooperate with veterinary medicine producers in order to diminish the use of certain medicines with high AMR-Impact; emphasizes that public-private partnerships are essential for the One- Health approach;
Amendment 123 #
Draft opinion
Paragraph 8 a (new)
Paragraph 8 a (new)
8a. Stresses that particularly in rural areas it is challenging to respond to livestock health issues in good time and that it therefore has proven irreplaceable to allow veterinarians to directly supply antibiotics;
Amendment 134 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls on the Commission and the Member States to align surveillance, monitoring and reporting of AMR patterns and pathogens; and submit this data to the Global Antimicrobial Resistance Surveillance System (GLASS); furthermore, underlines the utmost importance of systemic collection of all the relevant and comparable data on the volume of sales and the use of veterinary antimicrobial medicinal products, which should be analysed and published by the European Medicine Agency in annual reports; considers that this practice should be made mandatory through European legislation as soon as possible;
Amendment 135 #
Draft opinion
Paragraph 9
Paragraph 9
9. Notes that the use of antibiotics as growth promoters in food-producing animals has been banned in the EU since 2006; calls on the Commission to enforce this ban as a conditionality to all food imports from third countries through Free Trade Agreements;
Amendment 228 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls Stresses that particularly in rural areas it is challenging to respond the Commission and the Member States to restrict or stopo livestock health issues in good time and that therefore in some regions it has proven irreplaceable to allow veterinarians to directly supply antibiotics; calls on the Commission and the Member States to only address the sale of antibiotics by those doctors or veterinarians who prescribe them in a way that still allows a sufficiently fast supply of antibiotics for veterinary use in livestock;
Amendment 246 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11 a. Calls on the Commission to take firm action against the illegal sale of antimicrobial products in the EU;
Amendment 275 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
Amendment 287 #
Motion for a resolution
Paragraph 14
Paragraph 14
Amendment 374 #
Motion for a resolution
Paragraph 22
Paragraph 22
22. Notes the hesitant approach of the industry to develop ‘last-line’ antibiotics against bacteria that are resistant to all other antibiotics owing to expected low profitabilityat the business model for developing medicines is not suitable for antibiotic development since resistance can evolve over time and because they are meant to be used as a last resort; calls for incentives for this research and definition of the regulatory pathway;
Amendment 390 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. Calls on the Commission and Member States to work together with the industry to develop new incentive models that delink payment from prescribing volume;